ArticleScientific reports2025
Preparation and characteristics evaluation of chitosan-coated nanoliposomes containing ferrous sulfate.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Chitosan-coated lipid nanocarriers co-delivering curcumin and α-terpinene with enhanced larvicidal activity against Cx. pipiens via oxidative stress.Scientific reports · 2026Article
- Statistical optimization of chitosan-based synthesis strategies to generate albumin nanoparticles.Drug delivery and translational research · 2026Article
- Article
- Article
- Chitosan-Coated Liposomes for Intranasal Delivery of Ghrelin: Enhancing Bioavailability to the Central Nervous System.Pharmaceutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The nanoliposomes loaded with ferrous sulfate were prepared by thin-layer hydration sonication and coated with nano-chitosan. Chitosan coating (0.2% w/v) and various lecithin: ferrous sulfate ratios (5:1, 10:1, and 20:1 w/w) were characterized based on the antimicrobial activity, particle size, polydispersity index (PDI), zeta potential, and encapsulation efficiency. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of ferrous sulfate against Staphylococcus aureus ATCC 25,923, Bacillus cereus ATCC 11,778, Escherichia coli ATCC 2592, and Pseudomonas aeruginosa ATCC 9027 were 1000 and 1500 mg/mL, respectively. Nanoliposomes containing ferrous sulfate with a higher ratio of lecithin: ferrous sulfate (20:1 w/w) showed more potent antibacterial activity with the MIC and MBC values of 500 and 750 mg/mL against all test microorganisms. The particle size, PDI and zeta potential values of the nanoliposomes loaded with ferrous sulfate increased significantly compared to the free nanoliposomes (84.65 nm, 0.25, - 33.55 mV). Increasing the ratio of lecithin to ferrous sulfate from 5:1 to 20:1 (w/w) decreased the particle size (350.51 nm), PDI (0.22), and zeta potential (- 18.1 mV) and increased the encapsulation efficiency (84.6%) of ferrous sulfate loaded nanoliposomes (p < 0.05). Chitosan coating increased the antimicrobial activity of nanoliposomes toward positive values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.